Keros Therapeutics shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.0M | 380k | 15.83 |
| 2024-09-30 | $22M | 380k | 58.07 |
| 2024-06-30 | $23M | 499k | 45.70 |
| 2024-03-31 | $45M | 680k | 66.20 |
| 2023-12-31 | $23M | 580k | 39.76 |
| 2023-09-30 | $19M | 580k | 31.88 |
| 2023-06-30 | $23M | 580k | 40.18 |
| 2023-03-31 | $13M | 300k | 42.70 |
| 2021-06-30 | $18M | 427k | 42.47 |
| 2021-03-31 | $26M | 427k | 61.55 |
| 2020-12-31 | $24M | 346k | 70.54 |